Suven Life Sciences Limited (SUVEN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Suven Life Sciences Limited (SUVEN) has a cash flow conversion efficiency ratio of -0.368x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.03 Billion ≈ $-11.18 Million USD) by net assets (Rs2.81 Billion ≈ $30.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SUVEN company net worth for the company's overall valuation and market capitalisation.
Suven Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Suven Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Suven Life Sciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Suven Life Sciences Limited ranked by their cash flow conversion efficiency. Explore SUVEN cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Under Armour Inc C
NYSE:UA
|
0.076x |
|
Tianjin Tianyao Pharmaceuticals Co Ltd
SHG:600488
|
0.003x |
|
SANDUR MANGANESE AND IRON ORES LTD
NSE:SANDUMA
|
0.104x |
|
Anhui Xinlong Electrical Co Ltd
SHE:002298
|
0.036x |
|
Crystal Growth & Energy Equipment Co. Ltd. A
SHG:688478
|
N/A |
|
Shenyang Toly Bread Co Ltd
SHG:603866
|
0.043x |
|
Primax Electronics Ltd
TW:4915
|
0.053x |
|
Redcare Pharmacy NV
F:RDC
|
-0.039x |
Annual Cash Flow Conversion Efficiency for Suven Life Sciences Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Suven Life Sciences Limited from 2005 to 2025. View current stock price of Suven Life Sciences Limited for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs1.10 Billion ≈ $11.89 Million |
Rs-1.48 Billion ≈ $-16.06 Million |
-1.350x | -215.69% |
| 2024-03-31 | Rs2.70 Billion ≈ $29.20 Million |
Rs-1.15 Billion ≈ $-12.49 Million |
-0.428x | -55.59% |
| 2023-03-31 | Rs3.75 Billion ≈ $40.59 Million |
Rs-1.03 Billion ≈ $-11.16 Million |
-0.275x | +79.28% |
| 2022-03-31 | Rs961.45 Million ≈ $10.40 Million |
Rs-1.28 Billion ≈ $-13.79 Million |
-1.327x | -49.20% |
| 2021-03-31 | Rs1.08 Billion ≈ $11.68 Million |
Rs-960.24 Million ≈ $-10.38 Million |
-0.889x | +34.25% |
| 2020-03-31 | Rs1.43 Billion ≈ $15.50 Million |
Rs-1.94 Billion ≈ $-20.96 Million |
-1.352x | -3261.03% |
| 2019-03-31 | Rs8.31 Billion ≈ $89.87 Million |
Rs355.49 Million ≈ $3.84 Million |
0.043x | -53.06% |
| 2018-03-31 | Rs7.67 Billion ≈ $82.99 Million |
Rs699.36 Million ≈ $7.56 Million |
0.091x | -44.15% |
| 2017-03-31 | Rs6.67 Billion ≈ $72.13 Million |
Rs1.09 Billion ≈ $11.77 Million |
0.163x | +39.04% |
| 2016-03-31 | Rs5.95 Billion ≈ $64.40 Million |
Rs698.78 Million ≈ $7.56 Million |
0.117x | -54.10% |
| 2015-03-31 | Rs5.59 Billion ≈ $60.49 Million |
Rs1.43 Billion ≈ $15.46 Million |
0.256x | -44.27% |
| 2014-03-31 | Rs2.64 Billion ≈ $28.60 Million |
Rs1.21 Billion ≈ $13.12 Million |
0.459x | +130.90% |
| 2013-03-31 | Rs1.54 Billion ≈ $16.70 Million |
Rs306.86 Million ≈ $3.32 Million |
0.199x | -24.39% |
| 2012-03-31 | Rs1.28 Billion ≈ $13.79 Million |
Rs335.07 Million ≈ $3.62 Million |
0.263x | +503.70% |
| 2011-03-31 | Rs1.27 Billion ≈ $13.71 Million |
Rs55.16 Million ≈ $596.55K |
0.044x | -60.24% |
| 2010-03-31 | Rs1.18 Billion ≈ $12.77 Million |
Rs129.25 Million ≈ $1.40 Million |
0.109x | -63.45% |
| 2009-03-31 | Rs1.14 Billion ≈ $12.38 Million |
Rs342.73 Million ≈ $3.71 Million |
0.299x | +709.03% |
| 2008-03-31 | Rs1.06 Billion ≈ $11.51 Million |
Rs39.38 Million ≈ $425.92K |
0.037x | -76.86% |
| 2007-03-31 | Rs1.02 Billion ≈ $10.98 Million |
Rs162.41 Million ≈ $1.76 Million |
0.160x | +161.76% |
| 2006-03-31 | Rs902.12 Million ≈ $9.76 Million |
Rs55.13 Million ≈ $596.25K |
0.061x | +135.07% |
| 2005-03-31 | Rs811.85 Million ≈ $8.78 Million |
Rs21.11 Million ≈ $228.26K |
0.026x | -- |
About Suven Life Sciences Limited
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candida… Read more